JPRN-UMIN000031845已完成未知
Prospective study to investigate the resistant mechanism to afatinib treatment in EGFR mutation-positive non-small cell lung cancer - Prospective study to investigate the resistant mechanism to afatinib treatment in EGFR mutation-positive non-small cell lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with interstitial pneumonitis or pulmonary fibrosis 2)Patients with serious infection 3)Patients with unsteady angina or cardiac infarction 4)Patients with severe complication 5)Patients with active double cancer 6)Patients requiring medication influenced P glycoprotein 7)Patients with history of dosage afatinib 8)Patients with contraindication against afatinib 9)Patients with history of serious hypersensitivity or allergy 10)Pregnant, pregnancy suspect, nursing women, patients who plan to have a baby 11)Patients with complication with mental disease or a mind symptom, and are judged to have difficulty in participation in the study 12)Any other patients who are regarded as unsuitable for this study by the investigators
研究者
相似试验
已完成
不适用
Investigation of the effectiveness of resistant maltodextrin intake for 24 weeks on glycometabolismMale and female who are aged 20 years and older and who have high HbA1c levelsJPRN-UMIN000023970CPCC Company Limited30
进行中（未招募）
1 期
A follow up study designed to obtain long term data on subjects who either achieved a sustained virologic response or or did not achieve a sustained virologic response in an AbbVie sponsored hepatitis C studyMedDRA version: 17.0 Level: PT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestationsHepatitis CEUCTR2012-003073-26-BEAbbVie Deutschland GmbH & Co. KG478
进行中（未招募）
1 期
A follow up study designed to obtain long term data on subjects who either achieved a sustained virologic response or or did not achieve a sustained virologic response in an AbbVie sponsored hepatitis C studyMedDRA version: 18.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsHepatitis CEUCTR2012-003073-26-DEAbbVie Deutschland GmbH & Co. KG500
进行中（未招募）
1 期
A follow up study designed to obtain long term data on subjects who either achieved a sustained virologic response or or did not achieve a sustained virologic response in an AbbVie sponsored hepatitis C studyHepatitis CEUCTR2012-003073-26-DKAbbVie Deutschland GmbH & Co. KG500
进行中（未招募）
1 期
A follow up study designed to obtain long term data on subjects who either achieved a sustained virologic response or or did not achieve a sustained virologic response in an AbbVie sponsored hepatitis C studyMedDRA version: 16.0Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsHepatitis CEUCTR2012-003073-26-PTAbbVie Deutschland GmbH & Co. KG500